COVID-19 delayed prostate cancer early detection screening and treatments. It also ushered in an increased use of telemedicine for prostate cancer care which is anticipated to expand and become more of a standard of care. This session assessed the impact of the pandemic, with a focus on how the increased use of telemedicine will impact the prostate cancer racial disparity based on the experiences and perspectives of doctors and patients.
Prostate Cancer Educational Video's
